Information: Detta är inte den senaste versionen av datamodellen. Du hittar en versionsöversikt till vänster under versioner. Den senaste versionen hittar du här.
Information:
Fel:
ID
21053
Beskrivning
A Safety and Efficacy Trial of Aliskiren 150mg , 300 mg Compared to Ramipril 5mg, 10mg in the Elderly; ODM derived from: https://clinicaltrials.gov/show/NCT00368277
Länk
https://clinicaltrials.gov/show/NCT00368277
Nyckelord
Versioner (2)
- 2017-04-06 2017-04-06 -
- 2021-09-17 2021-09-17 -
Uppladdad den
6 april 2017
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Hypertension NCT00368277
Eligibility Hypertension NCT00368277
- StudyEvent: Eligibility
Similar models
Eligibility Hypertension NCT00368277
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Outpatients | Age
Item
male or female outpatients ≥ 65 years old.
boolean
C0029921 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
C0001779 (UMLS CUI [2])
Essential Hypertension | Sitting systolic blood pressure mean | Sitting diastolic blood pressure mean
Item
patients with essential hypertension with an mssbp ≥ 140 mmhg and < 180 mmhg, and msdbp < 110 mmhg at visits 2 and 3. (visit 201 was deleted by the administrative changes document.)
boolean
C0085580 (UMLS CUI [1])
C1319893 (UMLS CUI [2,1])
C0444504 (UMLS CUI [2,2])
C1319894 (UMLS CUI [3,1])
C0444504 (UMLS CUI [3,2])
C1319893 (UMLS CUI [2,1])
C0444504 (UMLS CUI [2,2])
C1319894 (UMLS CUI [3,1])
C0444504 (UMLS CUI [3,2])
Sitting systolic blood pressure mean Timepoint Difference
Item
patients must have had a difference in mssbp of ≤ 20 mmhg between visit 3 and the visit immediately prior to visit 3.
boolean
C1319893 (UMLS CUI [1,1])
C0444504 (UMLS CUI [1,2])
C2348792 (UMLS CUI [1,3])
C1705242 (UMLS CUI [1,4])
C0444504 (UMLS CUI [1,2])
C2348792 (UMLS CUI [1,3])
C1705242 (UMLS CUI [1,4])
Study Subject Participation Status | Informed Consent
Item
patients who were eligible and able to participate in the study, and who consented to do so after the purpose and nature of the investigation had been explained to them (written informed consent).
boolean
C2348568 (UMLS CUI [1])
C0021430 (UMLS CUI [2])
C0021430 (UMLS CUI [2])
Renal Artery Stenosis
Item
history of renal artery stenosis.
boolean
C0035067 (UMLS CUI [1])
Hypertensive Retinopathy Grade
Item
known keith-wagener grade iii or iv hypertensive retinopathy.
boolean
C0152132 (UMLS CUI [1,1])
C0441800 (UMLS CUI [1,2])
C0441800 (UMLS CUI [1,2])
Hypertensive Encephalopathy
Item
history of hypertensive encephalopathy.
boolean
C0151620 (UMLS CUI [1])
Heart failure New York Heart Association Classification
Item
current diagnosis of heart failure (new york heart association class iii-iv).
boolean
C0018801 (UMLS CUI [1,1])
C1275491 (UMLS CUI [1,2])
C1275491 (UMLS CUI [1,2])
Transient Ischemic Attack | Cerebrovascular accident
Item
history of transient ischemic cerebral attack or cerebrovascular accident within 6 months.
boolean
C0007787 (UMLS CUI [1])
C0038454 (UMLS CUI [2])
C0038454 (UMLS CUI [2])
Myocardial Infarction | Bypass surgery | Percutaneous Coronary Intervention
Item
history of myocardial infarction, bypass surgery, or any percutaneous coronary intervention within 6 months.
boolean
C0027051 (UMLS CUI [1])
C1536078 (UMLS CUI [2])
C1532338 (UMLS CUI [3])
C1536078 (UMLS CUI [2])
C1532338 (UMLS CUI [3])
Angina, Unstable | Nitrate Oral Dose Stable | Nitrate Topical Dose Stable | Adrenergic beta-1 Receptor Antagonists Dose Stable
Item
current unstable angina pectoris. patients on a stable dose of oral or topical nitrates or beta blockers for angina were acceptable.
boolean
C0002965 (UMLS CUI [1])
C0699857 (UMLS CUI [2,1])
C1527415 (UMLS CUI [2,2])
C0178602 (UMLS CUI [2,3])
C0205360 (UMLS CUI [2,4])
C0699857 (UMLS CUI [3,1])
C1522168 (UMLS CUI [3,2])
C0178602 (UMLS CUI [3,3])
C0205360 (UMLS CUI [3,4])
C0304516 (UMLS CUI [4,1])
C0178602 (UMLS CUI [4,2])
C0205360 (UMLS CUI [4,3])
C0699857 (UMLS CUI [2,1])
C1527415 (UMLS CUI [2,2])
C0178602 (UMLS CUI [2,3])
C0205360 (UMLS CUI [2,4])
C0699857 (UMLS CUI [3,1])
C1522168 (UMLS CUI [3,2])
C0178602 (UMLS CUI [3,3])
C0205360 (UMLS CUI [3,4])
C0304516 (UMLS CUI [4,1])
C0178602 (UMLS CUI [4,2])
C0205360 (UMLS CUI [4,3])
Cardiac Arrhythmia Life Threatening | ARRHYTHMIA SYMPTOMATIC
Item
concurrent potentially life threatening arrhythmia or symptomatic arrhythmia.
boolean
C0003811 (UMLS CUI [1,1])
C2826244 (UMLS CUI [1,2])
C0741212 (UMLS CUI [2])
C2826244 (UMLS CUI [1,2])
C0741212 (UMLS CUI [2])
Heart valve disease
Item
clinically significant valvular heart disease.
boolean
C0018824 (UMLS CUI [1])
Antihypertensive Agents | Adrenergic alpha-Antagonists Dose Stable | Benign prostatic hypertrophy | Flomax | Adrenergic beta-1 Receptor Antagonists | Angina Pectoris | Adrenergic beta-1 Receptor Antagonists Ophthalmic
Item
concurrent use of any antihypersensitive medications except a stable dose 3 months prior to visit 1 of alpha adrenergic blockers for benign prostatic hypertrophy (e.g., flomax for bph), beta blockers for angina, or beta blockers ophthalmic preparations.
boolean
C0003364 (UMLS CUI [1])
C0001641 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C0205360 (UMLS CUI [2,3])
C0005001 (UMLS CUI [3])
C0662903 (UMLS CUI [4])
C0304516 (UMLS CUI [5])
C0002962 (UMLS CUI [6])
C0304516 (UMLS CUI [7,1])
C1522230 (UMLS CUI [7,2])
C0001641 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C0205360 (UMLS CUI [2,3])
C0005001 (UMLS CUI [3])
C0662903 (UMLS CUI [4])
C0304516 (UMLS CUI [5])
C0002962 (UMLS CUI [6])
C0304516 (UMLS CUI [7,1])
C1522230 (UMLS CUI [7,2])